The Community Guide

- gsearch

Search Results

Narrow Results:

2023 2
2014 1

Journal Article 3

1 - 3 of 3 Results

Refine Results

Refine Results:

Nasal nitric oxide flux from the paranasal sinuses

CITE Title : Nasal nitric oxide flux from the paranasal sinuses Personal Author(s) : Spector, Barak M.;Shusterman, Dennis J.;Zhao, Kai; Published Date : 2 01 2023;2-01-; Source : Curr Opin Allergy Clin Immunol. 23(1):22-28 URL : https://stacks.cdc.gov/view/cdc/128330 Spector, Barak M. et al. (2023). Nasal nitric oxide flux from the paranasal sinuses. 23(1). Spector, Barak M. and Shusterman, Dennis J. and Zhao, Kai "Nasal nitric oxide flux from the paranasal sinuses" 23, no. 1 (2023) Spector, Barak M. et al. "Nasal nitric oxide flux from the paranasal sinuses" vol. 23, no. 1, 2023 Export RIS Citation Information.

:

Spector, Barak M. ;

Shusterman, Dennis J.

2 01 2023 | Curr Opin Allergy Clin Immunol. 23(1):22-28

:

Purpose of reviewUpper airway nitric oxide (NO) is physiologically important in airway regulation and defense, and can be modulated by various airway ...
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States

CITE Title : Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States Personal Author(s) : Shepardson, D.;Marks, S. M.;Chesson, H.;Kerrigan, A.;Holland, D. P.;Scott, N.;Tian, X.;Borisov, A. S.;Shang, N.;Heilig, C. M.;Sterling, T. R.;Villarino, M. E.;Mac Kenzie, W. R.; Published Date : 12-2013 Source : Int J Tuberc Lung Dis. 17(12):1531-1537 URL : https://stacks.cdc.gov/view/cdc/45950 Shepardson, D. et al. (2014). Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States. 17(12). Shepardson, D. et al. "Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States" 17, no. 12 (2014) Shepardson, D. et al. "Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States" vol. 17, no. 12, 2014 Export RIS Citation Information.

:

Shepardson, D. ;

Marks, S. M.

12-2013 | Int J Tuberc Lung Dis. 17(12):1531-1537

:

SETTINGA large randomized controlled trial recently showed that for treating latent tuberculous infection (LTBI) in persons at high risk of progressio...
Original Articles Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study

CITE Title : Original Articles Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study Personal Author(s) : Lee, Francis;Khanna, Aditya S.;Hallmark, Camden J.;Lavingia, Richa;McNeese, Marlene;Zhao, Jing;McNeese, Melanie;Khuwaja, Salma;Ardestani, Babak Mahdavi;Collier, Nicholson;Ozik, Jonathan;Hotton, Anna;Harawa, Nina T.;Schneider, John A.;Fujimoto, Kayo; Published Date : 1 2023;1-01-; Source : Med Care. 61(1):12-19 URL : https://stacks.cdc.gov/view/cdc/162083 Lee, Francis et al. (2023). Original Articles Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study. 61(1). Lee, Francis et al. "Original Articles Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study" 61, no. 1 (2023) Lee, Francis et al. "Original Articles Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study" vol. 61, no. 1, 2023 Export RIS Citation Information.

:

Lee, Francis ;

Khanna, Aditya S.

1 2023 | Med Care. 61(1):12-19

:

Context:Medicaid expansion has been nationally shown to improve engagement in the HIV treatment and prevention continua, which are vital steps to stop...